Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-04

FDA Approved: HEPZATO KIT — Supplemental Application (Delcath Systems, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Hepzato Kit (melphalan hydrochloride injection, lyophilized powder, for solution) from Delcath Systems, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEPZATO KIT (melphalan hydrochloride injection, lyophilized, for solution)

Snippet

SUPPL AP for HEPZATO KIT (MELPHALAN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION)